These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36570060)

  • 1. Accelerating policy response to curb non-communicable diseases: an imperative to mitigate the dual public health crises of non-communicable diseases and COVID-19 in India.
    Shrivastav R; Rawal T; Kataria I; Mehrotra R; Bassi S; Arora M
    Lancet Reg Health Southeast Asia; 2023 Mar; 10():100132. PubMed ID: 36570060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
    Allen LN; Wigley S; Holmer H; Barlow P
    Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracing Africa's progress towards implementing the Non-Communicable Diseases Global action plan 2013-2020: a synthesis of WHO country profile reports.
    Nyaaba GN; Stronks K; de-Graft Aikins A; Kengne AP; Agyemang C
    BMC Public Health; 2017 Apr; 17(1):297. PubMed ID: 28381252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
    NCD Countdown 2030 collaborators
    Lancet; 2018 Sep; 392(10152):1072-1088. PubMed ID: 30264707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of non-communicable diseases from infectious causes in 2017: a modelling study.
    Coates MM; Kintu A; Gupta N; Wroe EB; Adler AJ; Kwan GF; Park PH; Rajbhandari R; Byrne AL; Casey DC; Bukhman G
    Lancet Glob Health; 2020 Dec; 8(12):e1489-e1498. PubMed ID: 33098769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 SDG Collaborators
    Lancet; 2018 Nov; 392(10159):2091-2138. PubMed ID: 30496107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nations within a nation: variations in epidemiological transition across the states of India, 1990-2016 in the Global Burden of Disease Study.
    India State-Level Disease Burden Initiative Collaborators
    Lancet; 2017 Dec; 390(10111):2437-2460. PubMed ID: 29150201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A narrative review of gaps in the provision of integrated care for noncommunicable diseases in India.
    Pati MK; Swaroop N; Kar A; Aggarwal P; Jayanna K; Van Damme W
    Public Health Rev; 2020; 41():8. PubMed ID: 32435518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and accountability for the Pacific response to the non-communicable diseases crisis.
    Tolley H; Snowdon W; Wate J; Durand AM; Vivili P; McCool J; Novotny R; Dewes O; Hoy D; Bell C; Richards N; Swinburn B
    BMC Public Health; 2016 Sep; 16(1):958. PubMed ID: 27613495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The International Society for Behavioral Medicine (ISBM) and the Society of Behavioral Medicine (SBM) advocate for the inclusion of behavioral scientists in the implementation of the Global Action Plan for the prevention of non-communicable diseases (NCDs) in low- and middle-income countries.
    Odukoya O; Fox RS; Hayman LL; Penedo FJ
    Transl Behav Med; 2021 Jun; 11(6):1286-1288. PubMed ID: 33410489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The global diet and activity research (GDAR) network: a global public health partnership to address upstream NCD risk factors in urban low and middle-income contexts.
    Oni T; Assah F; Erzse A; Foley L; Govia I; Hofman KJ; Lambert EV; Micklesfield LK; Shung-King M; Smith J; Turner-Moss E; Unwin N; Wadende P; Woodcock J; Mbanya JC; Norris SA; Obonyo CO; Tulloch-Reid M; Wareham NJ;
    Global Health; 2020 Oct; 16(1):100. PubMed ID: 33076935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthy people and healthy profits? Elaborating a conceptual framework for governing the commercial determinants of non-communicable diseases and identifying options for reducing risk exposure.
    Buse K; Tanaka S; Hawkes S
    Global Health; 2017 Jun; 13(1):34. PubMed ID: 28619031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-communicable Disease Risk Reduction Teaching in India: A Curricular Landscape.
    Pati S; Sinha R; Mahapatra P
    Front Public Health; 2019; 7():133. PubMed ID: 31275913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What are the Evidence Based Public Health Interventions for Prevention and Control of NCDs in Relation to India?
    Singh K; Reddy KS; Prabhakaran D
    Indian J Community Med; 2011 Dec; 36(Suppl 1):S23-31. PubMed ID: 22628907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-communicable diseases and health systems reform in low-and-middle-income countries.
    Robinson HM; Hort K
    Pac Health Dialog; 2012 Apr; 18(1):179-90. PubMed ID: 23240355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect on longevity of one-third reduction in premature mortality from non-communicable diseases by 2030: a global analysis of the Sustainable Development Goal health target.
    Cao B; Bray F; Ilbawi A; Soerjomataram I
    Lancet Glob Health; 2018 Dec; 6(12):e1288-e1296. PubMed ID: 30420032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of poverty reduction and development interventions on non-communicable diseases and their behavioural risk factors in low and lower-middle income countries: A systematic review.
    Pullar J; Allen L; Townsend N; Williams J; Foster C; Roberts N; Rayner M; Mikkelsen B; Branca F; Wickramasinghe K
    PLoS One; 2018; 13(2):e0193378. PubMed ID: 29474454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Communicable or noncommunicable diseases? Building strong primary health care systems to address double burden of disease in India.
    Mohan P; Mohan SB; Dutta M
    J Family Med Prim Care; 2019 Feb; 8(2):326-329. PubMed ID: 30984632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.